These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22089489)

  • 1. Immunohistochemistry in the diagnostic evaluation of breast lesions.
    Hicks DG
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):501-5. PubMed ID: 22089489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of immunohistochemistry in diagnosis of breast epithelial lesions.
    Bhargava R; Dabbs DJ
    Adv Anat Pathol; 2007 Mar; 14(2):93-107. PubMed ID: 17471116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of immunohistochemistry in the diagnosis of problematic breast lesions.
    Lee AH
    J Clin Pathol; 2013 Jun; 66(6):471-7. PubMed ID: 23486609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions.
    Moriya T; Kanomata N; Kozuka Y; Fukumoto M; Iwachido N; Hata S; Takahashi Y; Miura H; Ishida K; Watanabe M
    Breast Cancer; 2009; 16(3):173-8. PubMed ID: 19475479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fine needle aspiration cytology diagnosis of ductal lesions of breast].
    Di F; Wong NL
    Zhonghua Bing Li Xue Za Zhi; 2010 Jul; 39(7):467-72. PubMed ID: 21055176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies to the proteins of intermediate filaments and of basement membranes in the differential diagnosis of certain forms of human breast tumors].
    Gel'shteĭn VI; Chipysheva TA; Ermilova VD; Liubimov AV
    Arkh Patol; 1990; 52(9):12-8. PubMed ID: 1702969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic immunohistochemistry of breast epithelial lesions].
    Balaton AJ; Guinebretière JM; Penault-Llorca F
    Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial hyperplasia of the breast. Comparison of incidence between cases of breast carcinoma and control autopsy specimens with immunohistochemical observation of blood group antigens.
    Inai K; Yamamoto A; Arihiro K; Khatun N; Kurihara K; Takeda S
    Acta Pathol Jpn; 1992 Mar; 42(3):193-200. PubMed ID: 1570741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant breast lesions that may mimic benign tumors.
    Weidner N
    Semin Diagn Pathol; 1995 Feb; 12(1):2-13. PubMed ID: 7770672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of monoclonal antibodies in the diagnostic distinction of gynecomastia from breast carcinoma in men.
    Mottolese M; Bigotti G; Coli A; Vitucci C; Natali PG
    Am J Clin Pathol; 1991 Aug; 96(2):233-7. PubMed ID: 1713740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic utility of CK5/6 and p63 in fine-needle aspiration of the breast lesions diagnosed as proliferative fibrocystic lesion.
    Al-Maghraby H; Ghorab Z; Khalbuss W; Wong J; Silverman JF; Saad RS
    Diagn Cytopathol; 2012 Feb; 40(2):141-7. PubMed ID: 22246930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD46 Expression is an unfavorable prognostic factor in breast cancer cases.
    Maciejczyk A; Szelachowska J; Szynglarewicz B; Szulc R; Szulc A; Wysocka T; Jagoda E; Lage H; Surowiak P
    Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):540-6. PubMed ID: 21617523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigens associated with epithelial ovarian carcinomas.
    Bast RC
    Prog Clin Biol Res; 1989; 288():73-83. PubMed ID: 2785696
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunohistochemical studies with monoclonal antibodies B72.3 and MA5 on histologic and cytologic specimens from benign and malignant breast lesions.
    Bergeron C; Shatz P; Margolese R; Major P; Ferenczy A
    Anal Quant Cytol Histol; 1989 Feb; 11(1):33-42. PubMed ID: 2719794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic Spectrum of Secretory and Mucinous Breast Lesions.
    Toll A; Joneja U; Palazzo J
    Arch Pathol Lab Med; 2016 Jul; 140(7):644-50. PubMed ID: 27362569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of immunohistochemistry in breast pathology: a review and update.
    Liu H
    Arch Pathol Lab Med; 2014 Dec; 138(12):1629-42. PubMed ID: 25427042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity.
    Goldstein NS; Hunter S; Forbes S; Odish E; Tehrani M
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):203-7. PubMed ID: 17525635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical reactivity of a mouse monoclonal antibody CDI 315B raised against human breast carcinoma.
    Beketić-Oresković L; Sarcević B; Malenica B; Novak D
    Neoplasma; 1993; 40(2):69-74. PubMed ID: 8394515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electronic expert consultation using digital still images for evaluation of atypical small acinar proliferations of the prostate: a comparison with immunohistochemistry.
    Banihashemi A; Asgari M; Shooshtarizade T; Abolhasani M; Mireskandari M
    Ann Diagn Pathol; 2014 Jun; 18(3):163-70. PubMed ID: 24767894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Immunohistochemical Stains in Epithelial Lesions of the Breast.
    Khazai L; Rosa M
    Cancer Control; 2015 Apr; 22(2):220-5. PubMed ID: 26068768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.